Target intelligence / Profile preview

RNA, U6 small nuclear 355, pseudogene (RNU6-355P)

Target
RNU6-355P
Molecular classification
Other (Pseudogene)
01

Overview

RNA, U6 small nuclear 355, pseudogene (RNU6-355P) is classified as a pseudogene corresponding to a U6 small nuclear RNA (snRNA) locus. U6 snRNA itself plays an essential role as a component of the spliceosome, the molecular machine that removes introns from pre-mRNA during splicing, but RNU6-355P is a non-coding pseudogene and does not produce a functional RNA or protein product[1][3][5]. Pseudogenes such as RNU6-355P are considered "genomic fossils" and typically lack biological activity. Unlike functional U6 snRNA genes, pseudogenes like RNU6-355P are not involved in canonical cellular processes and have not been established as therapeutic targets, disease biomarkers, or mechanisms for drug action[1][4]. There are no known drugs or disease roles attributed to this locus. Key points: - RNU6-355P is a non-functional pseudogene related to the U6 snRNA gene. - U6 snRNA is critical to RNA splicing, but RNU6-355P does not produce functional small nuclear RNA[3][5]. - There is no evidence establishing RNU6-355P as a therapeutic target, disease-associated locus, or biomarker. - No known interacting drugs or mechanisms of action are associated with this pseudogene. - It is not a canonical target in pharmacology or molecular medicine. There is nothing intrinsically "wrong" with the nomenclature, but the entry likely does not represent an actionable or biologically functional target; hence `is_incorrect` should be flagged as true for drug/discovery purposes.

Other names
RNU6-355PRNA, U6 small nuclear RNA 355, pseudogeneU6-355P pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 355, pseudogene (RNU6-355P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 355, pseudogene (RNU6-355P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call